Exosomal circCCAR1 released by HCC cells enhanced resistance to anti-PD-1 immunotherapy and reduced the survival time of HCC-bearing mice by retarding CD8+ T cell expansion and infiltration into tumor tissues. Here, CD8A is linked to neoplasm.